- Home
- NMAX vs RXRX Comparison
NMAX vs RXRX Comparison
Compare NMAX & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMAX
- RXRX
- Stock Information
- Founded
- NMAX 1998
- RXRX 2013
- Country
- NMAX United States
- RXRX United States
- Employees
- NMAX N/A
- RXRX N/A
- Industry
- NMAX
- RXRX Biotechnology: Pharmaceutical Preparations
- Sector
- NMAX
- RXRX Health Care
- Exchange
- NMAX NYSE
- RXRX Nasdaq
- Market Cap
- NMAX 3.0B
- RXRX 2.6B
- IPO Year
- NMAX 2025
- RXRX 2021
- Fundamental
- Price
- NMAX $19.75
- RXRX $4.37
- Analyst Decision
- NMAX
- RXRX Buy
- Analyst Count
- NMAX 0
- RXRX 5
- Target Price
- NMAX N/A
- RXRX $7.60
- AVG Volume (30 Days)
- NMAX 1.2M
- RXRX 21.1M
- Earning Date
- NMAX 05-15-2025
- RXRX 05-05-2025
- Dividend Yield
- NMAX N/A
- RXRX N/A
- EPS Growth
- NMAX N/A
- RXRX N/A
- EPS
- NMAX N/A
- RXRX N/A
- Revenue
- NMAX $175,718,517.00
- RXRX $59,790,000.00
- Revenue This Year
- NMAX N/A
- RXRX $39.85
- Revenue Next Year
- NMAX N/A
- RXRX $51.60
- P/E Ratio
- NMAX N/A
- RXRX N/A
- Revenue Growth
- NMAX 20.18
- RXRX 29.32
- 52 Week Low
- NMAX $14.00
- RXRX $3.79
- 52 Week High
- NMAX $265.00
- RXRX $12.36
- Technical
- Relative Strength Index (RSI)
- NMAX N/A
- RXRX 44.62
- Support Level
- NMAX N/A
- RXRX $4.11
- Resistance Level
- NMAX N/A
- RXRX $4.69
- Average True Range (ATR)
- NMAX 0.00
- RXRX 0.30
- MACD
- NMAX 0.00
- RXRX 0.04
- Stochastic Oscillator
- NMAX 0.00
- RXRX 51.90
About NMAX NEWSMAX INC
Newsmax Inc is a multi-platform media company. The company provides original news and lifestyle updates from its linear cable television and over-the-top (OTT) news channels, websites, proprietary database, publishing products, and e-commerce products. The Company uses original news and editorial content to draw large numbers of readers to its media outlets to sell advertising, print, and online information products. The Company's business operations are conducted through two operating segments, Broadcasting and Digital. The company generates maximum revenue from the Broadcasting Segment.
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.